EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Epidemiology of Renal Replacement Therapy for Critically Ill Patients across Seven Health Jurisdictions

Jennifer Ziegler, Katharine Morley, David Pilcher, Rinaldo Bellomo, Marcio Soares, Jorge I F Salluh, Lunna P Borges, Sean M Bagshaw, Darren Hudson, Christian F Christiansen, Uffe Heide-Jorgensen, Nazir I Lone und 4 weitere

American Journal of Nephrology · 18.06.2024 · 55 (5) · 539-550

DOI: 10.1159/000539811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nephrology, online erschienen am 18.06.2024. Verfasst von Jennifer Ziegler und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Critical Care Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, umzieglj@myumanitoba.ca. Hauptthemen laut MEDLINE: Renal Replacement Therapy, Acute Kidney Injury, Critical Illness, Intensive Care Units. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute kidney injury (AKI) requiring treatment with renal replacement therapy (RRT) is a common complication after admission to an intensive care unit (ICU) and is associated with significant morbidity and mortality. However, the prevalence of RRT use and the associated outcomes in critically patients across the globe are not well described. Therefore, we describe the epidemiology and outcomes of patients receiving RRT for AKI in ICUs across several large health system jurisdictions.

Methods

Retrospective cohort analysis using nationally representative and comparable databases from seven health jurisdictions in Australia, Brazil, Canada, Denmark, New Zealand, Scotland, and the USA between 2006 and 2023, depending on data availability of each dataset. Patients with a history of end-stage kidney disease receiving chronic RRT and patients with a history of renal transplant were excluded.

Results

A total of 4,104,480 patients in the ICU cohort and 3,520,516 patients in the mechanical ventilation cohort were included. Overall, 156,403 (3.8%) patients in the ICU cohort and 240,824 (6.8%) patients in the mechanical ventilation cohort were treated with RRT for AKI. In the ICU cohort, the proportion of patients treated with RRT was lowest in Australia and Brazil (3.3%) and highest in Scotland (9.2%). The in-hospital mortality for critically ill patients treated with RRT was almost fourfold higher (57.1%) than those not receiving RRT (16.8%). The mortality of patients treated with RRT varied across the health jurisdictions from 37 to 65%.

Conclusion

The outcomes of patients who receive RRT in ICUs throughout the world vary widely. Our research suggests that differences in access to and provision of this therapy are contributing factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Replacement TherapyAcute Kidney InjuryCritical IllnessIntensive Care UnitsHospital MortalityHumansMaleFemaleRetrospective StudiesMiddle AgedAgedBrazilAdultAustraliaUnited StatesCanadaNew ZealandRespiration, ArtificialDenmarkScotland

Stichwörter der Autor:innen

Acute kidney injuryIntensive care unitOutcomesRenal replacement therapy

Autor:innen und Institutionen

  • Department of Internal Medicine, Section of Critical Care Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, umzieglj@myumanitoba.ca.
  • Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • ANZICS Centre for Outcome and Resource Evaluation, Prahran, Victoria, Australia.
  • Department of Intensive Care, The Alfred Hospital, Prahran, Victoria, Australia.
  • The Australian and New Zealand Intensive Care - Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Förderung

  • NIBIB NIH HHS

Zitieren

APA

Ziegler, J., Morley, K., Pilcher, D., Bellomo, R., Soares, M., Salluh, J. I. F., Borges, L. P., Bagshaw, S. M., Hudson, D., Christiansen, C. F., Heide-Jorgensen, U., Lone, N. I., Buyx, A., McLennan, S., Celi, L. A., & Rush, B. (2024). Epidemiology of Renal Replacement Therapy for Critically Ill Patients across Seven Health Jurisdictions. American Journal of Nephrology, 55(5), 539-550. https://doi.org/10.1159/000539811

Vancouver

Ziegler J, Morley K, Pilcher D, Bellomo R, Soares M, Salluh JIF, et al. Epidemiology of Renal Replacement Therapy for Critically Ill Patients across Seven Health Jurisdictions. American Journal of Nephrology. 2024;55(5):539-550. doi:10.1159/000539811

BibTeX
@article{Ziegler2024,
  author = {Ziegler, Jennifer and Morley, Katharine and Pilcher, David and Bellomo, Rinaldo and Soares, Marcio and Salluh, Jorge I F and Borges, Lunna P and Bagshaw, Sean M and Hudson, Darren and Christiansen, Christian F and Heide-Jorgensen, Uffe and Lone, Nazir I and Buyx, Alena and McLennan, Stuart and Celi, Leo A and Rush, Barret},
  title = {Epidemiology of Renal Replacement Therapy for Critically Ill Patients across Seven Health Jurisdictions},
  journal = {American Journal of Nephrology},
  year = {2024},
  volume = {55},
  number = {5},
  pages = {539--550},
  doi = {10.1159/000539811}
}
Kostenlos starten →